CONSOL Remains Top Pick in Coal Space and 4 Stock Analyses to Know Now
February 11, 2013
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Current Price: $177.93
RBC Capital thinks that Regeneron is at an attractive entry point due to its belief that the market is undervaluing the near-term market opportunity of Regeneron’s Eylea treatment along with its broader pipeline. The firm recommends purchasing the stock on pullbacks and it keeps its Outperform rating on the stock.
Markets are off to the races and this stock is on fire. Click here to discover it now!
Premium Newsletters
Gold & Silver
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More
Commodities Premium
There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more
ETF Investing
At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more
Wall St. Cheat Sheet has been featured in these fine media outlets:
